SCHEMBL1990289

SCHEMBL1990289

NC(=O)c1ccc(C(N)=O)c(Cc2ccc(N)cc2)c1Cc1ccc(N)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.50
ALDH1A1 P00352 2/20 0.50
TSHR P16473 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
PLA2G2A P14555 4/20 0.41
PLA2G10 O15496 3/20 0.41
MITF O75030 1/20 0.40
GFER P55789 1/20 0.39
LOXL2 Q9Y4K0 1/20 0.38
CA12 O43570 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CA9 Q16790 1/20 0.38
CA14 Q9ULX7 1/20 0.38
AURKA O14965 1/20 0.38
RPS6KB1 P23443 1/20 0.38
CYP17A1 P05093 2/20 0.37
PARP10 Q53GL7 1/20 0.37
CYP19A1 P11511 1/20 0.37
CYP11B1 P15538 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL21646049 0.98 CYP3A4 (0.48) CYP3A4ALDH1A1TSHRTDP1PLA2G2A
SCHEMBL28681774 0.82 PLA2G2A (0.57) CYP3A4ALDH1A1TSHRTDP1PLA2G2A
SCHEMBL4952428 0.79 ALDH1A1 (0.50) CYP3A4ALDH1A1TSHRTDP1PLA2G2A
SCHEMBL4949010 0.76 ALDH1A1 (0.62) CYP3A4ALDH1A1TSHRTDP1PLA2G2A
SCHEMBL19439093 0.76 TSHR (0.53) CYP3A4ALDH1A1TSHRTDP1PLA2G2A
SCHEMBL30073173 0.73 HDAC1 (0.42) ALDH1A1TSHRTDP1GFERCA12
SCHEMBL28778955 0.73 PLA2G2A (0.47) ALDH1A1PLA2G2APLA2G10SLCO1B1
SCHEMBL5550889 0.73 PLA2G2A (0.47) ALDH1A1PLA2G2APLA2G10SLCO1B1
SCHEMBL28974830 0.72 MAPT (0.40) ALDH1A1TDP1RPS6KB1PARP10
SCHEMBL30824614 0.70 DGAT1 (0.41) ALDH1A1TSHRTDP1PARP10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2516503-B1 ANTIMICROBIAL POLYMERS AND METHODS OF MANUFACTURE THEREOF IBM (US) 2016-07-20 EP disclosed
US-9284404-B2 Antimicrobial polymers and methods of manufacture thereof INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2016-03-15 US disclosed
US-9084735-B2 Self-assembling bis-urea compounds for drug delivery INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2015-07-21 US disclosed
US-20150037390-A1 SELF-ASSEMBLING BIS-UREA COMPOUNDS FOR DRUG DELIVERY AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2015-02-05 US disclosed
US-8921426-B2 Cationic bis-urea compounds as effective antimicrobial agents INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2014-12-30 US disclosed
US-20130281515-A1 CATIONIC BIS-UREA COMPOUNDS AS EFFECTIVE ANTIMICROBIAL AGENTS AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2013-10-24 US disclosed
US-8361495-B2 Antimicrobial polymers and methods of manufacture thereof INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2013-01-29 US disclosed
US-20130011457-A1 ANTIMICROBIAL POLYMERS AND METHODS OF MANUFACTURE THEREOF AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2013-01-10 US disclosed
EP-2516503-A1 ANTIMICROBIAL POLYMERS AND METHODS OF MANUFACTURE THEREOF International Business Machines Corporation (US) 2012-10-31 EP disclosed
WO-2011078804-A1 ANTIMICROBIAL POLYMERS AND METHODS OF MANUFACTURE THEREOF INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2011-06-30 WO disclosed
US-20110150977-A1 ANTIMICROBIAL POLYMERS AND METHODS OF MANUFACTURE THEREOF AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2011-06-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130011457-A1 ANTIMICROBIAL POLYMERS AND METHODS OF MANUFACTURE THEREOF MLEC, NOD2, PAM CYP3A4 4614/4885ALDH1A1 3648/4885TSHR 4155/4885
US-20130281515-A1 CATIONIC BIS-UREA COMPOUNDS AS EFFECTIVE ANTIMICROBIAL AGENTS NOS3, NOS1, NOS2 CYP3A4 1443/4885ALDH1A1 4147/4885TSHR 2518/4885
US-20150037390-A1 SELF-ASSEMBLING BIS-UREA COMPOUNDS FOR DRUG DELIVERY SLC14A1, NONO, PUF60 CYP3A4 1581/4885ALDH1A1 4051/4885TSHR 4559/4885
US-20110150977-A1 ANTIMICROBIAL POLYMERS AND METHODS OF MANUFACTURE THEREOF MLEC, NOD2, PAM CYP3A4 4614/4885ALDH1A1 3648/4885TSHR 4155/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.